Oxford BioDynamics plc (OBD) Ordinary 1p Shares
Share news, reports & tips
16 June 2020 13:15
(Sharecast News) - Biotechnology company Oxford BioDynamics reported a fall in revenue to £0.2m in its interim results on Tuesday, from £0.6m a year earlier.
14 May 2020 16:01
(Sharecast News) - Oxford BioDynamics revealed on Thursday that interim chairman Stephen Diggle had acquired 30,000 ordinary shares in the AIM-listed biotechnology firm via his interest in Vulpes Testudo Fund.
11 December 2019 16:11
(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-listed biotechnology firm.
23 April 2019 10:33
(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all...
19 March 2019 11:43
(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based...
12 November 2018 09:24
(Sharecast News) - Oxford Biodynamics entered into a collaboration with Casa Sollievo della Sofferenza on Monday to research the blood-based diagnosis of Autism Spectrum Disorder (ASD).
22 August 2018 08:39
(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.
16 March 2018 10:04
(ShareCast News) - AIM-quoted biotechnology firm Oxford BioDynamics has presented its latest biomarker data in a plenary talk at the sixth World CNS Summit in Boston, Massachusetts after it identified...
14 February 2018 15:59
(ShareCast News) - Oxford BioDynamics announced on Wednesday that the company's novel technology platform EpiSwitch has received patent protection in India.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.